Frank Gansauge

Summary

Country: Germany

Publications

  1. ncbi request reprint Treatment of pancreatic cancer: challenge of the facts
    Hans G Beger
    World J Surg 27:1075-84. 2003
  2. ncbi request reprint Effectivity of long antigen exposition dendritic cell therapy (LANEXDC®) in the palliative treatment of pancreatic cancer
    F Gansauge
    Center for oncologic, endocrine and minimal invasive surgery, Silcherstr 36, 89231 Neu Ulm, Germany
    Curr Med Chem 20:4827-35. 2013
  3. ncbi request reprint The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer
    Frank Gansauge
    Center for Oncological, Endocrinological and Minimal access Surgery, University of Ulm, Silcherstr 36, 89231 Neu Ulm, Germany
    Hepatogastroenterology 54:917-20. 2007
  4. ncbi request reprint Systemic immune dysfunction in pancreatic cancer patients
    Bertram Poch
    Center for Oncological, Endocrinological and Minimal access Surgery, Silcherstr 36, 89231 Neu Ulm, Germany
    Langenbecks Arch Surg 392:353-8. 2007
  5. ncbi request reprint NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial
    Frank Gansauge
    Department of General Surgery, University of Ulm, Germany
    Langenbecks Arch Surg 386:570-4. 2002
  6. ncbi request reprint Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats
    Michael Schwarz
    Department of General Surgery, University of Ulm, Ulm, Germany
    Langenbecks Arch Surg 392:365-70. 2007
  7. ncbi request reprint Cyclooxygenase-2 is overexpressed in chronic pancreatitis
    Wolfgang Schlosser
    Department of General Surgery, University of Ulm, Ulm, Germany
    Pancreas 25:26-30. 2002
  8. ncbi request reprint Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma
    Carmela Beger
    Department of Pediatric Hematology, Hannover Medical School, Hannover, Germany
    Clin Cancer Res 10:3780-7. 2004
  9. ncbi request reprint Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats
    Uwe A Wittel
    Department of General, Visceral, and Transplantation Surgery, University of Freiburg, 79106 Freiburg, Germany
    Dig Dis Sci 49:1348-57. 2004
  10. doi request reprint Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas
    Hans G Beger
    c o Universitätsklinikum Ulm, Steinhovelstrasse 9, D 89075 Ulm, Germany
    J Hepatobiliary Pancreat Surg 15:149-56. 2008

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Treatment of pancreatic cancer: challenge of the facts
    Hans G Beger
    World J Surg 27:1075-84. 2003
    ..Therefore, after oncological resection of pancreatic cancer each patient should be offered adjuvant treatment. A neoadjuvant treatment protocol for pancreatic cancer, however, has not been established...
  2. ncbi request reprint Effectivity of long antigen exposition dendritic cell therapy (LANEXDC®) in the palliative treatment of pancreatic cancer
    F Gansauge
    Center for oncologic, endocrine and minimal invasive surgery, Silcherstr 36, 89231 Neu Ulm, Germany
    Curr Med Chem 20:4827-35. 2013
    ....
  3. ncbi request reprint The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer
    Frank Gansauge
    Center for Oncological, Endocrinological and Minimal access Surgery, University of Ulm, Silcherstr 36, 89231 Neu Ulm, Germany
    Hepatogastroenterology 54:917-20. 2007
    ..The aim of this study was to determine the effectiveness of the combined treatment with Gemcitabine and NSC-631570 in the adjuvant treatment of resected advanced pancreatic cancer...
  4. ncbi request reprint Systemic immune dysfunction in pancreatic cancer patients
    Bertram Poch
    Center for Oncological, Endocrinological and Minimal access Surgery, Silcherstr 36, 89231 Neu Ulm, Germany
    Langenbecks Arch Surg 392:353-8. 2007
    ..We investigated the immune status in 32 pancreatic cancer patients (PC) in comparison with healthy controls (HC)...
  5. ncbi request reprint NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial
    Frank Gansauge
    Department of General Surgery, University of Ulm, Germany
    Langenbecks Arch Surg 386:570-4. 2002
    ..It has been used in complementary herbal medicine for more than 20 years for the treatment of benign and malignant tumors...
  6. ncbi request reprint Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats
    Michael Schwarz
    Department of General Surgery, University of Ulm, Ulm, Germany
    Langenbecks Arch Surg 392:365-70. 2007
    ..The effect of two antibiotic regimens for early and late treatment was investigated in the taurocholate model of necrotizing pancreatitis in the rat...
  7. ncbi request reprint Cyclooxygenase-2 is overexpressed in chronic pancreatitis
    Wolfgang Schlosser
    Department of General Surgery, University of Ulm, Ulm, Germany
    Pancreas 25:26-30. 2002
    ..The constitutively expressed cyclooxygenase-1 (COX-1) appears to regulate many normal physiologic functions in several cell types, whereas the inducible cyclooxygenase-2 (COX-2) enzyme mediates the inflammatory response...
  8. ncbi request reprint Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma
    Carmela Beger
    Department of Pediatric Hematology, Hannover Medical School, Hannover, Germany
    Clin Cancer Res 10:3780-7. 2004
    ..However, as demonstrated for breast and ovarian cancer, inactivation of BRCA in sporadic diseases is based on alteration in gene expression or functional alteration...
  9. ncbi request reprint Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats
    Uwe A Wittel
    Department of General, Visceral, and Transplantation Surgery, University of Freiburg, 79106 Freiburg, Germany
    Dig Dis Sci 49:1348-57. 2004
    ..Only the treatment with anti-ICAM-1 mAb affected these changes, indicating that immunological changes in necrotizing pancreatitis are only in part affected by early PMN leukocyte-mediated pancreatic damage...
  10. doi request reprint Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas
    Hans G Beger
    c o Universitätsklinikum Ulm, Steinhovelstrasse 9, D 89075 Ulm, Germany
    J Hepatobiliary Pancreat Surg 15:149-56. 2008
    ..We report the following data from 15 patients treated surgically for cystic neoplastic lesions of the pancreas head...